chr14-67473716-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001348543.2(TMEM229B):c.208C>A(p.Arg70Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000437 in 1,603,662 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000034 ( 0 hom. )
Consequence
TMEM229B
NM_001348543.2 missense
NM_001348543.2 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.25
Genes affected
TMEM229B (HGNC:20130): (transmembrane protein 229B) Predicted to act upstream of or within response to bacterium. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25875795).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM229B | NM_001348543.2 | c.208C>A | p.Arg70Ser | missense_variant | 3/3 | ENST00000554480.6 | NP_001335472.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM229B | ENST00000554480.6 | c.208C>A | p.Arg70Ser | missense_variant | 3/3 | 2 | NM_001348543.2 | ENSP00000450859.2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151540Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
151540
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000432 AC: 1AN: 231434Hom.: 0 AF XY: 0.00000797 AC XY: 1AN XY: 125456
GnomAD3 exomes
AF:
AC:
1
AN:
231434
Hom.:
AF XY:
AC XY:
1
AN XY:
125456
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000344 AC: 5AN: 1452122Hom.: 0 Cov.: 30 AF XY: 0.00000416 AC XY: 3AN XY: 721614
GnomAD4 exome
AF:
AC:
5
AN:
1452122
Hom.:
Cov.:
30
AF XY:
AC XY:
3
AN XY:
721614
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151540Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74012
GnomAD4 genome
AF:
AC:
2
AN:
151540
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74012
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 30, 2021 | The c.208C>A (p.R70S) alteration is located in exon 3 (coding exon 1) of the TMEM229B gene. This alteration results from a C to A substitution at nucleotide position 208, causing the arginine (R) at amino acid position 70 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;D
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Benign
T;T;.;.
Polyphen
B;B;.;.
Vest4
MutPred
Gain of catalytic residue at G69 (P = 5e-04);Gain of catalytic residue at G69 (P = 5e-04);Gain of catalytic residue at G69 (P = 5e-04);Gain of catalytic residue at G69 (P = 5e-04);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at